elevated pre-treatment enzymuria was noted in all patient groups with acute myeloblastic leukaemias ( aml ) fab type m4 or 5 displaying higher activities than aml patients fab types m1-3 , which in turn were higher than those found in patients with myelomatosis and chronic lymphocytic leukaemia .
C0023467
acute myeloblastic
C0026998
aml